Chemours stock drops nearly 2% after final 'forever chemicals' deal announced
Shares of Chemours Co. (CC) dropped nearly 2% in the aftermarket Friday after the chemicals company, alongside DuPont de Nemours Inc. (DD) and Corteva Inc. (CTVA), said it has reached a final $1.85 billion deal in principle to settle claims they are responsible for so-called "forever chemicals" in drinking water in the U.S., hewing close to what the companies announced in early June. The $1.185 billion will go into a settlement fund the three companies will establish, with Chemours contributing about 50%, or about $592 million, and DuPont, with about $400 million, and Corteva, with about $193 million, contributing the remaining 50%. The settlement amounts will be funded by the companies in full and deposited into the water district settlement fund within ten business days following preliminary approval of the settlement by the court system, they said. Shares of DuPont fell 1.3%, while Corteva's were up 0.1%. Chemours and Corteva were spun off from DuPont's predecessor in the past few years. Last week, 3M Co. (MMM) announced its own "forever chemicals" proposed settlement.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-30-23 1740ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth